Department of Anesthesiology and Intensive Care, Sapienza University, Rome, Italy -
Azienda Ospedaliera Pisana, University of Pisa, Pisa, Italy.
Minerva Anestesiol. 2022 Apr;88(4):248-258. doi: 10.23736/S0375-9393.21.15860-2. Epub 2021 Oct 28.
Acute kidney injury (AKI) represents a frequent complication after orthotopic liver transplantation (OLT). This study aimed to evaluate early postoperative AKI incidence during the first 72 h after OLT, perioperative risk factors, and AKI impact on survival.
From January 2011 to December 2013, 1681 patients underwent OLT in 19 centers and were enrolled in this prospective cohort study.
According to RIFLE criteria, AKI occurred in 367 patients, 21.8% (R: 5.8%, I: 6.4%, F: 4.8%, L: 4.8%). Based on multivariate analysis, intraoperative risk factors for AKI were: administration of 5-10 RBCs (OR 1.8, 95% CI 1.3-2.7), dopamine use (OR 1.6, 95% CI 1.2-2.3), post-reperfusion syndrome (OR 1.5, 95% CI 1.0-2.3), surgical complications (OR 2.0, 95% CI 1.3-3.0), and cardiological complications (OR 2.2, 95% CI 1.2-4.0). Postoperative risk factors were: norepinephrine (OR 1.4, 95% CI 1.0-2.0), furosemide (OR 4.2, 95% CI 3.0-5.9), more than 10 RBCs transfusion, (OR 3.7, 95% CI 1.4-10.5), platelets administration (OR 1.6, 95% CI 1.1-2.4), fibrinogen administration (OR 3.0, 95% CI, 1.5-6.2), hepatic complications (OR 4.6, 95% CI 2.9-7.5), neurological complications (OR 2.4, 95% CI 1.5-3.7), and infectious complications (OR 2.7, 95% CI 1.8-4.3). NO-AKI patients' 5-year survival rate was higher than AKI patients (68.06, 95% CI 62.7-72.7 and 81.2, 95% CI 78.9-83.3, P<0.001).
AKI still remains an important risk factor for morbidity and mortality after OLT. Further research to develop new strategies aimed at preventing or minimizing post-OLT AKI is needed.
急性肾损伤(AKI)是肝移植(OLT)后常见的并发症。本研究旨在评估OLT 后 72 小时内早期术后 AKI 的发生率、围手术期危险因素以及 AKI 对生存率的影响。
2011 年 1 月至 2013 年 12 月,19 个中心的 1681 例患者接受了 OLT,并被纳入这项前瞻性队列研究。
根据 RIFLE 标准,367 例患者发生 AKI,发生率为 21.8%(R:5.8%,I:6.4%,F:4.8%,L:4.8%)。基于多变量分析,AKI 的术中危险因素为:输注 5-10 单位红细胞(OR 1.8,95%CI 1.3-2.7)、使用多巴胺(OR 1.6,95%CI 1.2-2.3)、再灌注后综合征(OR 1.5,95%CI 1.0-2.3)、手术并发症(OR 2.0,95%CI 1.3-3.0)和心脏并发症(OR 2.2,95%CI 1.2-4.0)。术后危险因素为:去甲肾上腺素(OR 1.4,95%CI 1.0-2.0)、呋塞米(OR 4.2,95%CI 3.0-5.9)、输注超过 10 单位红细胞(OR 3.7,95%CI 1.4-10.5)、血小板输注(OR 1.6,95%CI 1.1-2.4)、纤维蛋白原输注(OR 3.0,95%CI,1.5-6.2)、肝并发症(OR 4.6,95%CI 2.9-7.5)、神经系统并发症(OR 2.4,95%CI 1.5-3.7)和感染并发症(OR 2.7,95%CI 1.8-4.3)。NO-AKI 患者的 5 年生存率高于 AKI 患者(68.06%,95%CI 62.7-72.7 和 81.2%,95%CI 78.9-83.3,P<0.001)。
AKI 仍然是 OLT 后发病率和死亡率的一个重要危险因素。需要进一步研究开发旨在预防或最小化 OLT 后 AKI 的新策略。